10 research outputs found
[Fotografische Dokumentation zur Ausstellung "Das Zarte", Galerie Körnerpark, von Anne Brannys]
No full text[FOTOGRAFISCHE DOKUMENTATION ZUR AUSSTELLUNG "DAS ZARTE", GALERIE KÖRNERPARK, VON ANNE BRANNYS]
[Fotografische Dokumentation zur Ausstellung "Das Zarte", Galerie Körnerpark, von Anne Brannys] ([1.0])
Anne Brannys: Eine Enzyklopädie des Zarten (2017) ([1.0])
Anna Myga Kasten: o.T. (2014) ([1.2a ])
Mario Bierende: Zeppelin (2013) ([1.3])
Janine Hönig: Homemate (2012) ([1.4])
Sandy Volz: Hearts of Darkness (2006) ([3.1a])
Ileana Pascalau: Like the stain of breath upon a mirror (2010) ([3.2])
Edith Kollath: nothing will ever be the same (2011/2018) ([4.1a])
France Parsus: Stille Schatten (2014) ([4.3])
Jens Kloppmann: Bullet Holes (2010) ([5.5])
Harriet Groß: Dem Wind durchlässig (2018) ([6.1.1a])
Eleana Katanu: 72 (Serendipität) (2014) ([6.2])
Hartmut Stockter: Abhören von Vogelschritten (2008) ([6.3])
Maximilian Meier: Über das Zarte (2014) ([7.2a])
Ana Alenso: Breaking news (2017) ([7.8])
Marion Denis: Index (2009) ([8.1a])
Aaron Rahe: Heile deine Wunde und sie wird gezeigt (Band Aid Painting No 3) (2013) ([9.1])
Edith Kollath: thinking I’d last forever (Bibel & Koran) (2013/2018) ([9.2a]
BIODEGRADABILITY DETERMINATION OF VEGETAL ORIGINATED PACKAGING MATERIALS UNDER CONTROLLED COMPOSTING CONDITIONS
No full textThe paper presents methodologies for the determination of corn starch packaging ultimate biodegradability under controlled composting conditions by measurement of the amount of carbon dioxide evolved and the degree of packaging disintegration at the end of the test. The composting takes place in an installation with controlled temperature, aeration and humidity
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
No full textAging is the most prominent risk factor for late-onset Alzheimer’s disease. Aging associates with a chronic inflammatory state both in the periphery and in the central nervous system, the evidence thereof and the mechanisms leading to chronic neuroinflammation being discussed. Nonetheless, neuroinflammation is significantly enhanced by the accumulation of amyloid beta and accelerates the progression of Alzheimer’s disease through various pathways discussed in the present review. Decades of clinical trials targeting the 2 abnormal proteins in Alzheimer’s disease, amyloid beta and tau, led to many failures. As such, targeting neuroinflammation via different strategies could prove a valuable therapeutic strategy, although much research is still needed to identify the appropriate time window. Active research focusing on identifying early biomarkers could help translating these novel strategies from bench to bedside
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
No full textParkinson’s disease is a neurodegenerative disease exhibiting the fastest growth in incidence in recent years. As with most neurodegenerative diseases, the pathophysiology is incompletely elucidated, but compelling evidence implicates inflammation, both in the central nervous system and in the periphery, in the initiation and progression of the disease, although it is not yet clear what triggers this inflammatory response and where it begins. Gut dysbiosis seems to be a likely candidate for the initiation of the systemic inflammation. The therapies in current use provide only symptomatic relief, but do not interfere with the disease progression. Nonetheless, animal models have shown promising results with therapies that target various vicious neuroinflammatory cascades. Translating these therapeutic strategies into clinical trials is still in its infancy, and a series of issues, such as the exact timing, identifying biomarkers able to identify Parkinson’s disease in early and pre-symptomatic stages, or the proper indications of genetic testing in the population at large, will need to be settled in future guidelines
Sympathetic NPY controls glucose homeostasis, cold tolerance, and cardiovascular functions in mice
No full textSummary: Neuropeptide Y (NPY) is best known for its effects in the brain as an orexigenic and anxiolytic agent and in reducing energy expenditure. NPY is also co-expressed with norepinephrine (NE) in sympathetic neurons. Although NPY is generally considered to modulate noradrenergic responses, its specific roles in autonomic physiology remain under-appreciated. Here, we show that sympathetic-derived NPY is essential for metabolic and cardiovascular regulation in mice. NPY and NE are co-expressed in 90% of prevertebral sympathetic neurons and only 43% of paravertebral neurons. NPY-expressing neurons primarily innervate blood vessels in peripheral organs. Sympathetic-specific NPY deletion elicits pronounced metabolic and cardiovascular defects in mice, including reductions in insulin secretion, glucose tolerance, cold tolerance, and pupil size and elevated heart rate, while notably, however, basal blood pressure was unchanged. These findings provide insight into target tissue-specific functions of NPY derived from sympathetic neurons and imply its potential involvement in metabolic and cardiovascular diseases
Epidermoid Cyst of the Uterine Cervix, an Unusual Location: Literature Review and Case Report
No full textEpidermoid cysts are most often benign cystic lesions, with uterine cervical localisation being very unusual. We present the case of a 52-year-old female patient diagnosed with an epidermoid cyst at the level of the uterine cervix. A bioptic and haemostatic uterine curettage was performed, followed by total hysterectomy with bilateral adnexectomy. The histopathologic analysis and immunohistochemical essay of the resection specimens confirmed the cervical epidermoid cyst. The presence of high-risk HPV (human papillomavirus) was only seen in the cervical mucosa. The exact etiopathogenesis is unknown, but postpartum cell implantation of reminiscent embryonic tissue can be involved in the development of these lesions
Magnetic resonance used as a differential diagnostic tool between inflammatory cancer of the sigmoid and acute sigmoid diverticulitis
No full textSigmoid diverticulitis is a common disease characterized by a well-standardized diagnostic approach and treatment. Colorectal cancer is the third most common malignancy worldwide, irrespective of gender. In 2020, CRC global-related mortality rate was estimated at 935 173 cases, with an incidence of 9.3% in men and 9.5% in women. The diagnosis of acute diverticulitis is always made by performing a contrast-enhanced-computed tomography (CT) of the abdomen. Current diagnosis guidelines do not recommend the use of a magnetic resonance imaging (MRI) for further and more precise assessment of a suspected sigmoid diverticulitis diagnosed by CT. Early lower-gastrointestinal (lower-GI) endoscopy is rarely conducted; thus, the diagnosis delay could have a negative impact over the oncological outcome of the disease. Few and scarce data can be found related to this issue, with only a recent Swedish study paying attention towards early identification of neoplastic disease residing on a background of sigmoid diverticulitis, facilitated by MRI. The purpose of this study is to evaluate the feasibility of systematically performing an abdominal MRI included in the primary assessment of acute diverticulitis already diagnosed by CT, in order to argument in favor of an early lower-GI endoscopy where a positive MRI for neoplasia is found
